Meningioma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
Sergekorjian (talk | contribs) |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Meningioma}} | {{Meningioma}} | ||
{{CMG}} {{AE}}{{HL}} | {{CMG}} {{AE}} {{IO}} {{HL}} | ||
==Overview== | ==Overview== | ||
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of meningioma and a greater incidence of recurrence following surgical resection. | Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of meningioma and a greater incidence of recurrence following surgical resection. | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
===Bromodeoxyuridine Labeling Study=== | ===Bromodeoxyuridine Labeling Study=== | ||
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index of meningioma is associated with:<ref name="pmid2399811">{{cite journal| author=Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB| title=Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. | journal=Acta Neuropathol | year= 1990 | volume= 80 | issue= 3 | pages= 311-7 | pmid=2399811 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2399811 }} </ref> | |||
:* Rapid growth rate of the tumor | :* Rapid growth rate of the tumor | ||
:* Greater incidence of recurrence following surgical resection of the tumor | :* Greater incidence of recurrence following surgical resection of the tumor | ||
| Line 21: | Line 21: | ||
[[Category:Neurosurgery]] | [[Category:Neurosurgery]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 14:39, 10 September 2019
|
Meningioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Meningioma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Meningioma other diagnostic studies |
|
Risk calculators and risk factors for Meningioma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2] Haytham Allaham, M.D. [3]
Overview
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of meningioma and a greater incidence of recurrence following surgical resection.
Other Diagnostic Studies
Bromodeoxyuridine Labeling Study
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index of meningioma is associated with:[1]
- Rapid growth rate of the tumor
- Greater incidence of recurrence following surgical resection of the tumor
References
- ↑ Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB (1990). "Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence". Acta Neuropathol. 80 (3): 311–7. PMID 2399811.